BioLargo, Inc.: Proactive Investors Interview: BioLargo says its PFAS water testing program has been met with 'impressive response' from customers

BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact.

Friday, 10 September 2021

Proactive Investors Interview: BioLargo says its PFAS water testing program has been met with 'impressive response' from customers

Source: Proactive Investors (https://ca.proactiveinvestors.com/companies/news/960057/biolargo-says-its-pfas-water-testing-program-has-been-met-with--impressive-response--from-customers-960057.html)

BioLargo, Inc's Randy Moore and Tonya Chandler joined Proactive to speak about the group's new service testing customer water to detect per- and polyfluoroalkyl substances (PFAS) contamination levels.

The group say the program offers 'peace of mind and proof of concept' to customers who need PFAS water treatment solutions in the face of an uncertain and rapidly evolving technological and regulatory landscape. From there, BioLargo’s proprietary PFAS water treatment technology, the Aqueous Electrostatic Concentrator (AEC) is deployed.

Friday, 10 September 2021

Proactive Investors Interview: BioLargo says its PFAS water testing program has been met with 'impressive response' from customers

No comments:

Post a Comment